Log in
First-generation antihistamine

Doxylamine

Doxylamine is a first-generation ethanolamine H1 antihistamine with prominent sedative and anticholinergic properties. It is primarily used as a short-term sleep aid and, in combination with pyridoxine (vitamin B6), for the treatment of nausea and vomiting of pregnancy. The most testable fact is that doxylamine is one of only two drugs (along with pyridoxine) with FDA Pregnancy Category A status for treating morning sickness.

Practice questionsHigh-yield facts
Drug classFirst-generation H1 antihistamine (ethanolamine)
MechanismCompetitive H1 receptor antagonist with anticholinergic effects
Main usesInsomnia, nausea and vomiting of pregnancy
Key adverse effectMarked sedation and anticholinergic symptoms
6 min readFor medical studentsUpdated 2026-10-14

Mechanism of action

Doxylamine is a competitive antagonist at histamine H1 receptors in the central nervous system and peripheral tissues. By blocking H1 receptors in the tuberomammillary nucleus and cortex, it reduces arousal and promotes sedation, which accounts for its efficacy as a hypnotic agent.

In addition to H1 antagonism, doxylamine exhibits significant anticholinergic activity by blocking muscarinic acetylcholine receptors. This anticholinergic effect contributes to both its antiemetic properties and its adverse effect profile. The drug also has weak alpha-adrenergic blocking activity.

The antiemetic action results from antagonism of H1 and muscarinic receptors in the vomiting center and vestibular apparatus. When combined with pyridoxine, the antiemetic efficacy is enhanced through complementary mechanisms, making the combination effective for nausea and vomiting of pregnancy.

High-yield for exams
  • Doxylamine is a first-generation H1 antihistamine with prominent sedative and anticholinergic properties
  • Doxylamine-pyridoxine combination is the only FDA Pregnancy Category A drug approved for nausea and vomiting of pregnancy
  • Elimination half-life is 10-12 hours, longer than diphenhydramine, causing more next-day sedation
  • Appears on Beers Criteria as potentially inappropriate for elderly due to anticholinergic effects and fall risk
  • Overdose presents with anticholinergic toxidrome: delirium, flushed dry skin, mydriasis, urinary retention, hyperthermia
  • Contraindicated with MAOIs due to prolonged and intensified anticholinergic effects
  • Crosses blood-brain barrier readily, unlike second-generation antihistamines, causing CNS sedation
  • Tolerance to sedative effects develops within days to weeks, limiting use for chronic insomnia

Indications

Insomnia: Doxylamine is indicated for the short-term treatment of insomnia, particularly difficulty with sleep onset. It is available over-the-counter for this purpose and is one of the most commonly used non-prescription sleep aids.

Nausea and vomiting of pregnancy: In fixed-dose combination with pyridoxine (vitamin B6), doxylamine is FDA-approved for treatment of nausea and vomiting of pregnancy that does not respond to conservative management. This combination (previously marketed as Bendectin, now as Diclegis or Bonjesta) is the only FDA Pregnancy Category A medication specifically approved for morning sickness.

Allergic conditions: Like other first-generation antihistamines, doxylamine can be used off-label for allergic rhinitis, urticaria, and pruritus, though it is less commonly prescribed for these indications due to marked sedation.

Pharmacokinetics

Absorption: Doxylamine is well absorbed from the gastrointestinal tract after oral administration. Peak plasma concentrations are typically reached within 2 to 3 hours.

Distribution: The drug is lipophilic and crosses the blood-brain barrier readily, which accounts for its central sedative effects. It also crosses the placenta, though extensive safety data support its use in pregnancy.

Metabolism: Doxylamine undergoes hepatic metabolism primarily via N-demethylation by cytochrome P450 enzymes, particularly CYP2D6. The drug is metabolized to both active and inactive metabolites.

Elimination: Excretion occurs primarily through the kidneys, with both unchanged drug and metabolites appearing in urine. The elimination half-life ranges from 10 to 12 hours, which is longer than many other antihistamines and contributes to next-day sedation or hangover effects.

Special populations: Elderly patients may experience prolonged effects due to decreased renal clearance and increased sensitivity to anticholinergic effects.

Adverse effects

Central nervous system: Marked sedation and drowsiness are the most common adverse effects and are typically dose-dependent. Next-day grogginess or hangover effect may occur. Paradoxical excitation can occur, particularly in children and elderly patients. Dizziness, disturbed coordination, and cognitive impairment may impair driving and operating machinery.

Anticholinergic effects: Dry mouth, blurred vision, urinary retention, constipation, and mydriasis are common. These effects result from muscarinic receptor blockade and are particularly problematic in elderly patients.

Cardiovascular: Tachycardia and palpitations may occur due to anticholinergic effects. Hypotension is possible, particularly with overdose.

Gastrointestinal: Nausea, epigastric distress, and increased appetite can occur despite the drug's antiemetic properties in pregnancy.

Other: Thickening of bronchial secretions, chest tightness, diplopia, and rash are reported. Acute angle-closure glaucoma can be precipitated in susceptible individuals.

Overdose: Anticholinergic toxidrome is the hallmark of doxylamine overdose, presenting with delirium, hallucinations, hyperthermia, flushed dry skin, dilated pupils, urinary retention, decreased bowel sounds, and tachycardia. Seizures and cardiac arrhythmias may occur in severe cases.

Contraindications and warnings

Absolute contraindications:

  • Hypersensitivity to doxylamine or other ethanolamines
  • Neonates and premature infants
  • Nursing mothers (drug is excreted in breast milk and may cause sedation or paradoxical excitation in infants)
  • Concurrent monoamine oxidase inhibitor (MAOI) therapy

Relative contraindications and warnings:

  • Narrow-angle glaucoma: Anticholinergic effects can precipitate acute angle-closure glaucoma
  • Prostatic hypertrophy or bladder neck obstruction: Risk of urinary retention
  • Asthma and COPD: Thickening of bronchial secretions may worsen respiratory conditions
  • Hyperthyroidism: Increased risk of tachycardia and cardiovascular effects
  • Cardiovascular disease: Use caution due to potential for tachycardia and hypotension
  • Peptic ulcer or pyloroduodenal obstruction: Anticholinergic effects may worsen these conditions
  • Hepatic or renal impairment: Dose adjustment may be necessary

Elderly patients: Doxylamine appears on the Beers Criteria list of potentially inappropriate medications for older adults due to high risk of anticholinergic adverse effects, delirium, cognitive impairment, and falls.

Pregnancy and lactation: The doxylamine-pyridoxine combination is Pregnancy Category A and safe for use in pregnancy. However, monotherapy with doxylamine alone has less robust safety data. Doxylamine is excreted in breast milk and is generally contraindicated during breastfeeding.

Drug interactions

CNS depressants: Additive sedation occurs with alcohol, benzodiazepines, opioids, barbiturates, other sedating antihistamines, and sedative-hypnotics. Patients should be warned to avoid alcohol and use caution with other CNS depressants.

Anticholinergic agents: Additive anticholinergic effects occur with tricyclic antidepressants, antipsychotics (particularly low-potency phenothiazines), antiparkinsonian drugs, and other antihistamines. This can lead to severe anticholinergic toxicity.

MAO inhibitors: MAOIs prolong and intensify the anticholinergic effects of antihistamines. Concurrent use is contraindicated, and a washout period of at least 14 days is required after discontinuing MAOIs.

CYP2D6 interactions: Drugs that inhibit CYP2D6 (e.g., fluoxetine, paroxetine, quinidine, bupropion) may increase doxylamine levels and enhance adverse effects. CYP2D6 poor metabolizers may also experience enhanced effects.

Ototoxic drugs: Doxylamine may mask early signs of ototoxicity from aminoglycosides or other ototoxic agents.

Central anticholinergic syndrome: When combined with other anticholinergics, doxylamine can contribute to central anticholinergic syndrome, which may present as confusion, agitation, hallucinations, and delirium.

Clinical pearls

  • Doxylamine is the sedating component of the doxylamine-pyridoxine combination (Diclegis/Bonjesta) for morning sickness; pyridoxine enhances antiemetic efficacy but does not contribute to sedation.
  • The elimination half-life of 10-12 hours is longer than diphenhydramine (4-8 hours), making next-day hangover effects more common with doxylamine.
  • Doxylamine is approximately equipotent to diphenhydramine but may cause more pronounced anticholinergic effects at equivalent doses.
  • The drug appears on the Beers Criteria list and should be avoided in elderly patients due to high risk of confusion, falls, and anticholinergic toxicity.
  • Tolerance to the sedative effects develops with regular use, typically within a few days to weeks, limiting its utility for chronic insomnia.
  • In overdose, physostigmine (a reversible acetylcholinesterase inhibitor) can be used to reverse severe anticholinergic symptoms, but it carries risks of cholinergic crisis and bradycardia and should be reserved for life-threatening cases.
  • Unlike second-generation antihistamines (cetirizine, loratadine, fexofenadine), doxylamine readily crosses the blood-brain barrier due to high lipophilicity and lack of P-glycoprotein efflux, accounting for pronounced CNS effects.
  • The safety profile of doxylamine-pyridoxine in pregnancy is supported by decades of use and multiple large epidemiological studies showing no increased risk of teratogenicity. This makes it the first-line pharmacologic option for nausea and vomiting of pregnancy.
  • When used as a sleep aid, doxylamine should be taken 30 minutes before bedtime and should be reserved for short-term use (less than 2 weeks) to minimize tolerance and dependence on sleep aids.
  • The anticholinergic burden of doxylamine contributes to cognitive impairment with chronic use, and cumulative anticholinergic exposure has been associated with increased dementia risk in observational studies.

Practice questions

1. A 28-year-old woman at 8 weeks gestation presents with mild nausea and occasional vomiting that has not improved with dietary modifications. She is able to tolerate some oral intake and fluids. Physical examination is normal. Which of the following is the most appropriate first-line pharmacologic treatment?

Answer: C. Doxylamine-pyridoxine is the only FDA Pregnancy Category A medication specifically approved for nausea and vomiting of pregnancy and should be first-line pharmacologic therapy for patients who can tolerate oral intake. It has decades of safety data with no increased risk of teratogenicity. Ondansetron, while commonly used, has conflicting data regarding potential cardiac malformations and is not first-line. Metoclopramide and phenothiazines like promethazine and prochlorperazine are second-line options with less robust pregnancy safety data.

2. A 72-year-old man with benign prostatic hyperplasia is brought to the emergency department by his family for confusion and agitation that began 6 hours ago. He reports he has been taking an over-the-counter sleep aid for the past week. On examination, his temperature is 38.2°C (100.8°F), pulse is 118/min, and blood pressure is 145/92 mmHg. He is disoriented and picking at the air. His skin is flushed and dry, pupils are dilated and poorly reactive, and mucous membranes are dry. Bladder is palpable above the pubic symphysis. Which of the following medications most likely caused this presentation?

Answer: C. This patient presents with classic anticholinergic toxidrome: hyperthermia, tachycardia, flushed dry skin, mydriasis, delirium with agitation, and urinary retention. Doxylamine is a first-generation antihistamine with potent anticholinergic effects and is a common ingredient in over-the-counter sleep aids. Elderly men with prostatic hyperplasia are at particular risk for urinary retention. The mnemonic for anticholinergic toxicity is 'hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter.' Zolpidem, eszopiclone, melatonin, and trazodone do not cause this syndrome.

3. A 45-year-old woman taking doxylamine-pyridoxine for nausea and vomiting of pregnancy at 10 weeks gestation reports persistent drowsiness that interferes with her work as a teacher. She asks which component of the medication is causing the sedation. Which of the following best explains the mechanism of this adverse effect?

Answer: B. Doxylamine causes sedation by blocking histamine H1 receptors in the central nervous system, particularly in the tuberomammillary nucleus and cortex, reducing arousal. Pyridoxine (vitamin B6) does not cause sedation; it is included for its antiemetic properties and works through a different mechanism. The sedation is solely attributable to doxylamine, which is a lipophilic first-generation antihistamine that readily crosses the blood-brain barrier. Doxylamine does not inhibit MAO, and there is no synergistic sedative metabolite.

Frequently asked questions

How does doxylamine work?

Doxylamine works by competitively blocking histamine H1 receptors in the central nervous system, reducing arousal and promoting sedation. It also has anticholinergic effects from blocking muscarinic acetylcholine receptors, which contribute to its antiemetic properties and side effects like dry mouth and urinary retention. The combination of H1 and muscarinic receptor antagonism makes it effective for both insomnia and nausea.

What are the side effects of doxylamine?

The most common side effects are marked sedation, drowsiness, and next-day grogginess. Anticholinergic effects include dry mouth, blurred vision, urinary retention, constipation, and dilated pupils. Dizziness, disturbed coordination, and cognitive impairment can occur. In elderly patients, confusion, delirium, and increased fall risk are concerns. Paradoxical excitation may occur in children and older adults.

Is doxylamine safe during pregnancy?

Yes, the doxylamine-pyridoxine combination is FDA Pregnancy Category A and is considered safe during pregnancy. It is the only medication specifically approved by the FDA for nausea and vomiting of pregnancy. Decades of use and multiple large studies have shown no increased risk of birth defects. However, doxylamine alone has less robust safety data, so the fixed-dose combination is preferred.

Doxylamine vs diphenhydramine — what is the difference?

Both are first-generation H1 antihistamines used for sleep and allergies, but doxylamine has a longer elimination half-life (10-12 hours vs 4-8 hours for diphenhydramine), causing more next-day sedation. Doxylamine may have more pronounced anticholinergic effects at equivalent doses. Doxylamine is specifically approved in combination with pyridoxine for morning sickness, while diphenhydramine is not. Both appear on Beers Criteria as potentially inappropriate for elderly patients.

Can you take doxylamine every night?

Doxylamine should only be used for short-term treatment of insomnia, typically less than two weeks. Tolerance to its sedative effects develops rapidly, usually within a few days to weeks of regular use, reducing its effectiveness. Chronic use increases anticholinergic burden, which is associated with cognitive impairment and potentially increased dementia risk. If insomnia persists beyond two weeks, evaluation for underlying causes and alternative treatments should be considered.

Conditions it is used for

InsomniaNausea and vomiting of pregnancyMorning sicknessAllergic rhinitisUrticariaPruritus
diphenhydraminepyridoxinepromethazinedimenhydrinatemeclizinehydroxyzinechlorpheniramineondansetron

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: R06AA09

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.